BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29787597)

  • 1. Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study.
    Chachaj A; Wiśniewski J; Rybka J; Butrym A; Biedroń M; Krzystek-Korpacka M; Fleszar MG; Karczewski M; Wróbel T; Mazur G; Gamian A; Szuba A
    PLoS One; 2018; 13(5):e0197148. PubMed ID: 29787597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased dickkopf-1 levels in chronic lymphocytic leukemia and increased osteopontin levels in non-Hodgkin's lymphoma at initial diagnosis: Could they be playing roles in pathogenesis?
    Pamuk GE; Uyanik MS; Pamuk ON; Maden M; Tapan U
    Hematology; 2015 Jun; 20(5):267-71. PubMed ID: 25271869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric dimethylarginine in hematological malignancies: a preliminary study.
    Szuba A; Chachaj A; Wróbel T; Dzietczenia J; Mazur G; Antonowicz-Juchniewicz J; Kuliczkowski K; Andrzejak R
    Leuk Lymphoma; 2008 Dec; 49(12):2316-20. PubMed ID: 19052979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of symmetric dimethyl-arginine are associated with all-cause mortality in patients with symptomatic peripheral arterial disease.
    Staniszewska A; Rajagopalan S; Al-Shaheen A; Thies F; Brittenden J
    J Vasc Surg; 2015 May; 61(5):1292-8. PubMed ID: 25776186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study.
    Aucella F; Maas R; Vigilante M; Tripepi G; Schwedhelm E; Margaglione M; Gesualdo L; Boeger R; Zoccali C
    Atherosclerosis; 2009 Dec; 207(2):541-5. PubMed ID: 19501358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of asymmetric and symmetric dimethylarginines in plasma of hyperhomocysteinemic subjects.
    Paroni R; Fermo I; Fiorina P; Cighetti G
    Amino Acids; 2005 Jun; 28(4):389-94. PubMed ID: 15827687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.
    Shafi T; Hostetter TH; Meyer TW; Hwang S; Hai X; Melamed ML; Banerjee T; Coresh J; Powe NR
    Am J Kidney Dis; 2017 Jul; 70(1):48-58. PubMed ID: 28089476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of homoarginine and methylarginines with liver dysfunction and mortality in chronic liver disease.
    Pilz S; Putz-Bankuti C; Meinitzer A; März W; Kienreich K; Stojakovic T; Pieber TR; Stauber RE
    Amino Acids; 2015 Sep; 47(9):1817-26. PubMed ID: 25952253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The L-Arginine-asymmetric dimethylarginine ratio is an independent predictor of mortality in dilated cardiomyopathy.
    Anderssohn M; Rosenberg M; Schwedhelm E; Zugck C; Lutz M; Lüneburg N; Frey N; Böger RH
    J Card Fail; 2012 Dec; 18(12):904-11. PubMed ID: 23207078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial injury in rheumatoid arthritis: a crosstalk between dimethylarginines and systemic inflammation.
    Dimitroulas T; Hodson J; Sandoo A; Smith J; Kitas GD
    Arthritis Res Ther; 2017 Feb; 19(1):32. PubMed ID: 28183353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unchanged plasma levels of dimethylarginines and nitric oxide in chronic hepatitis C.
    Lluch P; Cortina B; Vila JM; Segarra G; Mauricio MD; del Olmo JA; Serra MA; Lluch S; Rodrigo JM
    Scand J Gastroenterol; 2009; 44(2):224-8. PubMed ID: 18951278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in plasma levels of asymmetric dimethylarginine, symmetric dimethylarginine, and arginine after a single dose of vardenafil in patients with pulmonary hypertension.
    Henrohn D; Sandqvist A; Egeröd H; Hedeland M; Wernroth L; Bondesson U; Wikström G
    Vascul Pharmacol; 2015 Oct; 73():71-7. PubMed ID: 25934511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher serum asymmetric dimethylarginine is related to higher risk of heart failure in the EPIC-Potsdam study.
    Wirth J; Atzler D; di Giuseppe R; Cordts K; Menzel J; Böger RH; Boeing H; Weikert C; Schwedhelm E
    Amino Acids; 2017 Jan; 49(1):173-182. PubMed ID: 27796501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions.
    Erdélyi-Bótor S; Komáromy H; Kamson DO; Kovács N; Perlaki G; Orsi G; Molnár T; Illes Z; Nagy L; Kéki S; Deli G; Bosnyák E; Trauninger A; Pfund Z
    Cephalalgia; 2017 May; 37(6):571-580. PubMed ID: 27206959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course of endogenous nitric oxide inhibitors in severe sepsis in humans.
    Iapichino G; Umbrello M; Albicini M; Spanu P; Bellani G; Polli F; Pavlovic R; Cugno M; Fermo I; Paroni R
    Minerva Anestesiol; 2010 May; 76(5):325-33. PubMed ID: 20395894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum reference intervals of homoarginine, ADMA, and SDMA in the study of health in Pomerania.
    Atzler D; Schwedhelm E; Nauck M; Ittermann T; Böger RH; Friedrich N
    Clin Chem Lab Med; 2014 Dec; 52(12):1835-42. PubMed ID: 24945429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-Arginine Derivatives Are Associated with the Hyperthyroid State in the General Population.
    Ittermann T; Bahls M; Atzler D; Friedrich N; Schwedhelm E; Böger RH; Felix SB; Völzke H; Dörr M
    Thyroid; 2016 Feb; 26(2):212-8. PubMed ID: 26650143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease.
    Hov GG; Aasarød KI; Sagen E; Åsberg A
    Clin Biochem; 2015 Jul; 48(10-11):646-51. PubMed ID: 25828044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric dimethylarginine levels in thyroid diseases.
    Arikan E; Karadag CH; Guldiken S
    J Endocrinol Invest; 2007 Mar; 30(3):186-91. PubMed ID: 17505150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease.
    Böger RH; Endres HG; Schwedhelm E; Darius H; Atzler D; Lüneburg N; von Stritzky B; Maas R; Thiem U; Benndorf RA; Diehm C
    J Intern Med; 2011 Mar; 269(3):349-61. PubMed ID: 21175900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.